Antibody type N/A
Stock availability Available
Antibody host N/A
Technical datasheet Contact Gentaur to request the datasheet or ask our specialists for more information.
Antibody conjugate N/A
Notes The Inhibitory iODN- class I/II hybrid, may also affect TLR7 and TLR8 signaling. is manufactured for Research Use Only or for diagnostics purposes.
Description Cell nucleus signaling proteins and molecules are part of a complex system of communication that governs basic cellular activities and coordinates cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity as well as normal tissue homeostasis. Errors in cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated effectively and, theoretically, artificial tissues may be created.
Short name Inhibitory iODN- class I/II hybrid, may also affect TLR7 TLR8 signaling.
Alternative name Inhibitory iODN- class I/II hybrid, may also affect toll-like receptor 7 and toll-like receptor 8 signaling.
Alternative to gene target toll-like receptor 7, TLR7 and IDBG-44230 and ENSG00000196664 and 51284, siRNA binding, Plasma membranes, Tlr7 and IDBG-185532 and ENSMUSG00000044583 and 170743, TLR7 and IDBG-639302 and ENSBTAG00000022161 and 493686, toll-like receptor 8, TLR8 and IDBG-44288 and ENSG00000101916 and 51311, drug binding, Plasma membranes, Tlr8 and IDBG-185523 and ENSMUSG00000040522 and 170744